Bio-Rad Labs Inc. A Stock
Bio-Rad Labs Inc. A Stock
There is an upward development for Bio-Rad Labs Inc. A compared to yesterday, with an increase of €2.40 (1.110%).
Currently there is a rather positive sentiment for Bio-Rad Labs Inc. A with 5 Buy predictions and 0 Sell predictions.
As a result the target price of 334 € shows a very positive potential of 53.0% compared to the current price of 218.3 € for Bio-Rad Labs Inc. A.
For the coming years our community has positive and negative things to say abot the Bio-Rad Labs Inc. A stock. Criterium "Revenue growth" gathered the most positive votes but regarding "Revenue growth" there were negative voices in the community.
Pros and Cons of Bio-Rad Labs Inc. A in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Rad Labs Inc. A vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Rad Labs Inc. A | 1.110% | -15.067% | -22.226% | -18.313% | -16.285% | -49.872% | -60.385% |
| Haemonetics Corp. | 2.470% | -12.793% | -26.107% | - | -29.343% | - | - |
| Merit Medical Systems | 0.740% | 1.493% | -1.449% | -33.333% | -8.108% | 5.426% | 38.211% |
| Bio-Techne Corp. | 0.990% | -2.679% | -9.917% | -14.844% | 9.000% | -24.306% | - |
Comments
Bio-Rad Laboratories (NYSE:BIO) had its price target raised by analysts at Citigroup Inc. from $350.00 to $375.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BIO provided by MarketBeat
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at Royal Bank Of Canada from $387.00 to $409.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for BIO provided by MarketBeat
Bio-Rad Laboratories, Inc. (NYSE: BIO) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for BIO provided by MarketBeat